AJ
Abhishek Jain
About Abhishek Jain
Data last updated:
Abhishek Jain is a Nominee Director at Transaction Solutions International (India) Private Limited (since 2025), Nominee Director at Saimirra Innopharm Private Limited (since 2025) and Nominee Director at 3 Gen Consulting Services Private Limited (since 2025). The companies operate in Information Technology, Pharma and Business Outsourcing. The 3 current companies with reported revenue have a combined latest revenue of ₹576 Cr; the largest is Transaction Solutions International (India) Private Limited at ₹368 Cr (FY 2025). Earlier, Abhishek Jain was a Nominee Director at Biodeal Pharmaceuticals Limited (2025–2026) and Nominee Director at Harmony Organics Private Limited (2025–2026) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Transaction Solutions International (India) Private Limited U72200DL2005PTC135086 | Nominee Director | 08 May 2025 | 2005 | ₹368 Cr (FY 2025) | Active |
 Saimirra Innopharm Private Limited U24232TN2000PTC044315 | Nominee Director | 19 Jul 2025 | 2000 | ₹133 Cr (FY 2025) | Active |
 3 Gen Consulting Services Private Limited U70200MH2023PTC407930 | Nominee Director | 21 Feb 2025 | 2023 | ₹75.86 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biodeal Pharmaceuticals Limited U00304HP2005PLC029451 | Nominee Director | 16 May 2025 | 2005 | ₹209 Cr (FY 2025) | Active |
 Harmony Organics Private Limited U24110PN2003PTC200427 | Nominee Director | 29 May 2025 | 2003 | ₹316 Cr (FY 2025) | Active |
 E3i Health Private Limited U85100DL2021PTC382078 | Nominee Director | 22 Jul 2025 | 2021 | ₹40 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Abhishek Jain
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhishek Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhishek Jain
Abhishek Jain currently holds 3 directorships: Transaction Solutions International (India) Private Limited (Nominee Director, since 08 May 2025, revenue ₹368 Cr (FY 2025)); Saimirra Innopharm Private Limited (Nominee Director, since 19 Jul 2025, revenue ₹133 Cr (FY 2025)); 3 Gen Consulting Services Private Limited (Nominee Director, since 21 Feb 2025, revenue ₹75.86 Cr (FY 2025)).
Abhishek Jain was first appointed on 21 Feb 2025 as Nominee Director at 3 Gen Consulting Services Private Limited.
The 3 current companies of Abhishek Jain that report revenue have a combined latest revenue of ₹576 Cr: Transaction Solutions International (India) Private Limited ₹368 Cr (FY 2025); Saimirra Innopharm Private Limited ₹133 Cr (FY 2025); 3 Gen Consulting Services Private Limited ₹75.86 Cr (FY 2025).
Abhishek Jain held 3 earlier board appointments: Biodeal Pharmaceuticals Limited (Nominee Director, 16 May 2025 to 05 Aug 2026); Harmony Organics Private Limited (Nominee Director, 29 May 2025 to 01 May 2026); E3i Health Private Limited (Nominee Director, 22 Jul 2025 to 10 Feb 2026).
The current boards of Abhishek Jain's companies include Deepak Verma (Transaction Solutions International (India) Private Limited), Deepak Verma (Transaction Solutions International (India) Private Limited), Nicholas John Smedley (Transaction Solutions International (India) Private Limited), Seema Gupta (Transaction Solutions International (India) Private Limited), Anushree Manmohan Chandak (Saimirra Innopharm Private Limited), Ayyavu Rajavel (Saimirra Innopharm Private Limited), among others.